

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NADH metabolic process (GO:0006734) | 6.45515204 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.17155078 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.17155078 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.12596305 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.12596305 |
| 6 | lysine catabolic process (GO:0006554) | 5.70173585 |
| 7 | lysine metabolic process (GO:0006553) | 5.70173585 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.66699637 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 5.52693737 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.28451206 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.27711112 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 5.21391493 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.20509934 |
| 14 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.14724052 |
| 15 | cysteine metabolic process (GO:0006534) | 5.01571919 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.97838049 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 4.97838049 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 4.97838049 |
| 19 | amino-acid betaine metabolic process (GO:0006577) | 4.85544428 |
| 20 | bile acid biosynthetic process (GO:0006699) | 4.82325907 |
| 21 | serine family amino acid catabolic process (GO:0009071) | 4.80544485 |
| 22 | epoxygenase P450 pathway (GO:0019373) | 4.77482345 |
| 23 | regulation of triglyceride catabolic process (GO:0010896) | 4.73760835 |
| 24 | tryptophan metabolic process (GO:0006568) | 4.69910341 |
| 25 | angiotensin maturation (GO:0002003) | 4.66802562 |
| 26 | * fatty acid beta-oxidation (GO:0006635) | 4.65613815 |
| 27 | cellular ketone body metabolic process (GO:0046950) | 4.62064937 |
| 28 | 2-oxoglutarate metabolic process (GO:0006103) | 4.61246079 |
| 29 | urea metabolic process (GO:0019627) | 4.57987128 |
| 30 | urea cycle (GO:0000050) | 4.57987128 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.45608112 |
| 32 | acetyl-CoA metabolic process (GO:0006084) | 4.45003511 |
| 33 | complement activation, alternative pathway (GO:0006957) | 4.42785200 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 4.42530070 |
| 35 | * fatty acid oxidation (GO:0019395) | 4.36801267 |
| 36 | fatty acid transmembrane transport (GO:1902001) | 4.32291777 |
| 37 | fructose metabolic process (GO:0006000) | 4.31604546 |
| 38 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.30621380 |
| 39 | valine metabolic process (GO:0006573) | 4.30392563 |
| 40 | oxaloacetate metabolic process (GO:0006107) | 4.30256313 |
| 41 | alpha-amino acid catabolic process (GO:1901606) | 4.27546566 |
| 42 | high-density lipoprotein particle remodeling (GO:0034375) | 4.27212351 |
| 43 | * lipid oxidation (GO:0034440) | 4.27196780 |
| 44 | aspartate family amino acid catabolic process (GO:0009068) | 4.25757659 |
| 45 | nitrogen cycle metabolic process (GO:0071941) | 4.25173427 |
| 46 | protein carboxylation (GO:0018214) | 4.25157785 |
| 47 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.25157785 |
| 48 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.22547366 |
| 49 | * fatty acid catabolic process (GO:0009062) | 4.22201664 |
| 50 | regulation of protein activation cascade (GO:2000257) | 4.21650002 |
| 51 | ethanol oxidation (GO:0006069) | 4.21488609 |
| 52 | creatine metabolic process (GO:0006600) | 4.21241441 |
| 53 | carnitine metabolic process (GO:0009437) | 4.14586279 |
| 54 | carnitine shuttle (GO:0006853) | 4.13843980 |
| 55 | bile acid metabolic process (GO:0008206) | 4.12821811 |
| 56 | glycine metabolic process (GO:0006544) | 4.12765279 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.11512558 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.11512558 |
| 59 | regulation of fibrinolysis (GO:0051917) | 4.09486475 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 4.07446764 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 4.07068668 |
| 62 | * monocarboxylic acid catabolic process (GO:0072329) | 4.03390353 |
| 63 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.01756586 |
| 64 | branched-chain amino acid catabolic process (GO:0009083) | 4.00997151 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 3.99950750 |
| 66 | ketone body metabolic process (GO:1902224) | 3.98935270 |
| 67 | regulation of complement activation (GO:0030449) | 3.97477156 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 3.97233184 |
| 69 | biotin metabolic process (GO:0006768) | 3.90964948 |
| 70 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.89983349 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.89602940 |
| 72 | * organic acid catabolic process (GO:0016054) | 3.86441447 |
| 73 | * carboxylic acid catabolic process (GO:0046395) | 3.86441447 |
| 74 | negative regulation of cholesterol transport (GO:0032375) | 3.84530569 |
| 75 | negative regulation of sterol transport (GO:0032372) | 3.84530569 |
| 76 | branched-chain amino acid metabolic process (GO:0009081) | 3.84382844 |
| 77 | diacylglycerol metabolic process (GO:0046339) | 3.83434366 |
| 78 | regulation of sequestering of triglyceride (GO:0010889) | 3.82727718 |
| 79 | * short-chain fatty acid metabolic process (GO:0046459) | 3.82598883 |
| 80 | tyrosine metabolic process (GO:0006570) | 3.78424809 |
| 81 | reverse cholesterol transport (GO:0043691) | 3.75508769 |
| 82 | protein-lipid complex remodeling (GO:0034368) | 3.75063481 |
| 83 | macromolecular complex remodeling (GO:0034367) | 3.75063481 |
| 84 | plasma lipoprotein particle remodeling (GO:0034369) | 3.75063481 |
| 85 | coenzyme catabolic process (GO:0009109) | 3.74750177 |
| 86 | ethanol metabolic process (GO:0006067) | 3.74519275 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 3.73889980 |
| 88 | tricarboxylic acid metabolic process (GO:0072350) | 3.70245265 |
| 89 | phospholipid homeostasis (GO:0055091) | 3.69075229 |
| 90 | regulation of cholesterol esterification (GO:0010872) | 3.68885383 |
| 91 | exogenous drug catabolic process (GO:0042738) | 3.67402418 |
| 92 | glutamate metabolic process (GO:0006536) | 3.66070169 |
| 93 | regulation of cholesterol homeostasis (GO:2000188) | 3.65860444 |
| 94 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.65107546 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 3.65057191 |
| 96 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.64613290 |
| 97 | positive regulation of fatty acid oxidation (GO:0046321) | 3.63141951 |
| 98 | cellular glucuronidation (GO:0052695) | 3.59462475 |
| 99 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.57415024 |
| 100 | regulation of fatty acid oxidation (GO:0046320) | 3.55444614 |
| 101 | phospholipid efflux (GO:0033700) | 3.55443090 |
| 102 | drug catabolic process (GO:0042737) | 3.55377515 |
| 103 | benzene-containing compound metabolic process (GO:0042537) | 3.54957120 |
| 104 | tricarboxylic acid cycle (GO:0006099) | 3.54212188 |
| 105 | drug metabolic process (GO:0017144) | 3.53385065 |
| 106 | drug transmembrane transport (GO:0006855) | 3.48905237 |
| 107 | bile acid and bile salt transport (GO:0015721) | 3.46317011 |
| 108 | indolalkylamine metabolic process (GO:0006586) | 3.43846041 |
| 109 | muscle filament sliding (GO:0030049) | 3.41756822 |
| 110 | actin-myosin filament sliding (GO:0033275) | 3.41756822 |
| 111 | urate metabolic process (GO:0046415) | 3.39902607 |
| 112 | regulation of cholesterol metabolic process (GO:0090181) | 3.38954801 |
| 113 | carnitine transport (GO:0015879) | 3.37093291 |
| 114 | amino-acid betaine transport (GO:0015838) | 3.37093291 |
| 115 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.36359713 |
| 116 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.28677869 |
| 117 | intestinal absorption (GO:0050892) | 3.26243259 |
| 118 | triglyceride catabolic process (GO:0019433) | 3.12131509 |
| 119 | low-density lipoprotein particle clearance (GO:0034383) | 3.09750927 |
| 120 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.07864659 |
| 121 | quinone biosynthetic process (GO:1901663) | 2.96335996 |
| 122 | skeletal muscle contraction (GO:0003009) | 2.95357392 |
| 123 | protein-lipid complex assembly (GO:0065005) | 2.94499333 |
| 124 | neutral lipid catabolic process (GO:0046461) | 2.92402245 |
| 125 | acylglycerol catabolic process (GO:0046464) | 2.92402245 |
| 126 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.90302344 |
| 127 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.86419233 |
| 128 | lipoprotein transport (GO:0042953) | 2.86279158 |
| 129 | regulation of guanylate cyclase activity (GO:0031282) | 2.86264034 |
| 130 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.82717704 |
| 131 | arginine metabolic process (GO:0006525) | 2.82490828 |
| 132 | gluconeogenesis (GO:0006094) | 2.82311607 |
| 133 | hormone catabolic process (GO:0042447) | 2.81925317 |
| 134 | complement activation, classical pathway (GO:0006958) | 2.81839640 |
| 135 | uronic acid metabolic process (GO:0006063) | 2.79995748 |
| 136 | glucuronate metabolic process (GO:0019585) | 2.79995748 |
| 137 | plasma lipoprotein particle assembly (GO:0034377) | 2.78092880 |
| 138 | succinate metabolic process (GO:0006105) | 2.77596288 |
| 139 | actin-mediated cell contraction (GO:0070252) | 2.75260903 |
| 140 | transcytosis (GO:0045056) | 2.73970686 |
| 141 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.71336248 |
| 142 | glycosphingolipid catabolic process (GO:0046479) | 2.70469700 |
| 143 | complement activation (GO:0006956) | 2.70156711 |
| 144 | omega-hydroxylase P450 pathway (GO:0097267) | 2.70066739 |
| 145 | protein-lipid complex subunit organization (GO:0071825) | 2.69578798 |
| 146 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.68698289 |
| 147 | regulation of cholesterol storage (GO:0010885) | 2.64153144 |
| 148 | glucan catabolic process (GO:0009251) | 2.62912842 |
| 149 | glycolipid catabolic process (GO:0019377) | 2.61158774 |
| 150 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.59735335 |
| 151 | plasma lipoprotein particle organization (GO:0071827) | 2.59503175 |
| 152 | hexose biosynthetic process (GO:0019319) | 2.59126818 |
| 153 | polyketide metabolic process (GO:0030638) | 2.56976234 |
| 154 | doxorubicin metabolic process (GO:0044598) | 2.56976234 |
| 155 | daunorubicin metabolic process (GO:0044597) | 2.56976234 |
| 156 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.56057791 |
| 157 | endocrine process (GO:0050886) | 2.56057791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.92976723 |
| 2 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.28567384 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.98254761 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.27808984 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.33691371 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.90272014 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.21784847 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.04417682 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.00994889 |
| 10 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.48415157 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.36418591 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.99562703 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.31130298 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.10533223 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.86339109 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.84569338 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82919671 |
| 18 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.73269408 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69195907 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66050689 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64942311 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.51487914 |
| 23 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.48000132 |
| 24 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.41844384 |
| 25 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41571484 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41180327 |
| 27 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.40856461 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38542820 |
| 29 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36884641 |
| 30 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.35580779 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34861881 |
| 32 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.34708393 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33675186 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31570835 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31234560 |
| 36 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.29662667 |
| 37 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28092157 |
| 38 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26825899 |
| 39 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26605513 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.25645720 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24872609 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24695221 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.23767805 |
| 44 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.23452181 |
| 45 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.22963332 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22737869 |
| 47 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22207108 |
| 48 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21487401 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21432899 |
| 50 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21040251 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20507646 |
| 52 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18251906 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16768145 |
| 54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.16515773 |
| 55 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14044055 |
| 56 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13583017 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.13416284 |
| 58 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13252372 |
| 59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13019794 |
| 60 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12971150 |
| 61 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12139441 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12028721 |
| 63 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.11977951 |
| 64 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11351036 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10061953 |
| 66 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09645685 |
| 67 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07719064 |
| 68 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07406863 |
| 69 | MYC_22102868_ChIP-Seq_BL_Human | 1.07302397 |
| 70 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07264999 |
| 71 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.07008595 |
| 72 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06600827 |
| 73 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.06489346 |
| 74 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.06470645 |
| 75 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.05614814 |
| 76 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03732773 |
| 77 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.03697872 |
| 78 | MAF_26560356_Chip-Seq_TH2_Human | 1.03233646 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01764294 |
| 80 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01177764 |
| 81 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98569206 |
| 82 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98307470 |
| 83 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98136849 |
| 84 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98136849 |
| 85 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97892246 |
| 86 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96870319 |
| 87 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96310042 |
| 88 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95889674 |
| 89 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92504361 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.91187277 |
| 91 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90865398 |
| 92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90454705 |
| 93 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.89076732 |
| 94 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.86773670 |
| 95 | ATF3_27146783_Chip-Seq_COLON_Human | 0.85849019 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82524537 |
| 97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81685049 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81240993 |
| 99 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78134721 |
| 100 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76490448 |
| 101 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76332258 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.74759682 |
| 103 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.74366129 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72601728 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71691193 |
| 106 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70163893 |
| 107 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.69808901 |
| 108 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.69461780 |
| 109 | P68_20966046_ChIP-Seq_HELA_Human | 0.69103824 |
| 110 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.69011774 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.68879855 |
| 112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.68639551 |
| 113 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.67925087 |
| 114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.67383365 |
| 115 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.66221639 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.64958662 |
| 117 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.64869363 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64796785 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.64479984 |
| 120 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.64162518 |
| 121 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.64087529 |
| 122 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.63576349 |
| 123 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.63535530 |
| 124 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.63091839 |
| 125 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.62957689 |
| 126 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61951502 |
| 127 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.61717581 |
| 128 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.61526498 |
| 129 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.61125547 |
| 130 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.60850320 |
| 131 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.60695845 |
| 132 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.60539991 |
| 133 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.60124959 |
| 134 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.60061442 |
| 135 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59878904 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.58429997 |
| 137 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58368190 |
| 138 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.58163435 |
| 139 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.58069500 |
| 140 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57285227 |
| 141 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.56961760 |
| 142 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.56073141 |
| 143 | GATA2_19941826_ChIP-Seq_K562_Human | 0.54680996 |
| 144 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.54598485 |
| 145 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.54285481 |
| 146 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54128462 |
| 147 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.53930281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.72470878 |
| 2 | MP0005360_urolithiasis | 6.42252620 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.22167854 |
| 4 | MP0005365_abnormal_bile_salt | 5.09459544 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.05283888 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.91438525 |
| 7 | MP0003252_abnormal_bile_duct | 3.30455867 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.21098787 |
| 9 | MP0009840_abnormal_foam_cell | 3.12678795 |
| 10 | MP0005332_abnormal_amino_acid | 2.80631607 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.47631488 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.47332467 |
| 13 | MP0005083_abnormal_biliary_tract | 2.42808860 |
| 14 | MP0005670_abnormal_white_adipose | 2.30258286 |
| 15 | MP0003195_calcinosis | 2.29571759 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.18415839 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.07410866 |
| 18 | * MP0000609_abnormal_liver_physiology | 2.05831444 |
| 19 | MP0004130_abnormal_muscle_cell | 1.99846581 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.96210701 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 1.91225055 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 1.88243364 |
| 23 | MP0004145_abnormal_muscle_electrophysio | 1.79646454 |
| 24 | MP0005666_abnormal_adipose_tissue | 1.76835419 |
| 25 | MP0003646_muscle_fatigue | 1.73120586 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.72184204 |
| 27 | MP0004147_increased_porphyrin_level | 1.67134300 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 1.65867026 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.60786568 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59510326 |
| 31 | MP0003303_peritoneal_inflammation | 1.56841302 |
| 32 | * MP0009643_abnormal_urine_homeostasis | 1.54318928 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.53258383 |
| 34 | MP0003436_decreased_susceptibility_to | 1.48844333 |
| 35 | MP0001764_abnormal_homeostasis | 1.46134434 |
| 36 | MP0003186_abnormal_redox_activity | 1.44174038 |
| 37 | MP0005330_cardiomyopathy | 1.42681960 |
| 38 | MP0005451_abnormal_body_composition | 1.40098552 |
| 39 | MP0003724_increased_susceptibility_to | 1.32956996 |
| 40 | MP0004084_abnormal_cardiac_muscle | 1.30876670 |
| 41 | MP0009785_altered_susceptibility_to | 1.29547893 |
| 42 | MP0005166_decreased_susceptibility_to | 1.28665344 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.27762672 |
| 44 | MP0002971_abnormal_brown_adipose | 1.27543949 |
| 45 | MP0005025_abnormal_response_to | 1.23981931 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.23200862 |
| 47 | MP0003868_abnormal_feces_composition | 1.19539025 |
| 48 | MP0002822_catalepsy | 1.19369104 |
| 49 | MP0000598_abnormal_liver_morphology | 1.17476445 |
| 50 | MP0000759_abnormal_skeletal_muscle | 1.13769998 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.13123308 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.12678072 |
| 53 | MP0008260_abnormal_autophagy | 1.09287636 |
| 54 | MP0003866_abnormal_defecation | 1.08682572 |
| 55 | MP0009379_abnormal_foot_pigmentation | 1.08075944 |
| 56 | MP0003879_abnormal_hair_cell | 1.06035162 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.05652121 |
| 58 | MP0003075_altered_response_to | 1.04101545 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.01884438 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.01241399 |
| 61 | MP0004036_abnormal_muscle_relaxation | 1.01069402 |
| 62 | MP0002269_muscular_atrophy | 1.00831714 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.00615548 |
| 64 | MP0000751_myopathy | 0.98649053 |
| 65 | MP0005375_adipose_tissue_phenotype | 0.98440545 |
| 66 | MP0001835_abnormal_antigen_presentation | 0.97552310 |
| 67 | MP0001790_abnormal_immune_system | 0.96890904 |
| 68 | MP0005387_immune_system_phenotype | 0.96890904 |
| 69 | MP0001873_stomach_inflammation | 0.95636665 |
| 70 | MP0005165_increased_susceptibility_to | 0.95422590 |
| 71 | MP0002419_abnormal_innate_immunity | 0.94985946 |
| 72 | MP0004087_abnormal_muscle_fiber | 0.94538675 |
| 73 | MP0006035_abnormal_mitochondrial_morpho | 0.94519215 |
| 74 | MP0005636_abnormal_mineral_homeostasis | 0.94354859 |
| 75 | MP0005266_abnormal_metabolism | 0.93896635 |
| 76 | MP0005334_abnormal_fat_pad | 0.92456318 |
| 77 | MP0010368_abnormal_lymphatic_system | 0.92094408 |
| 78 | MP0004215_abnormal_myocardial_fiber | 0.91534093 |
| 79 | MP0009763_increased_sensitivity_to | 0.91421170 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91378920 |
| 81 | MP0004510_myositis | 0.91328345 |
| 82 | * MP0002078_abnormal_glucose_homeostasis | 0.90517114 |
| 83 | MP0001845_abnormal_inflammatory_respons | 0.90437980 |
| 84 | MP0001756_abnormal_urination | 0.89407531 |
| 85 | MP0009333_abnormal_splenocyte_physiolog | 0.88475164 |
| 86 | MP0001663_abnormal_digestive_system | 0.88350218 |
| 87 | MP0004858_abnormal_nervous_system | 0.88235480 |
| 88 | MP0005385_cardiovascular_system_phenoty | 0.87767373 |
| 89 | MP0001544_abnormal_cardiovascular_syste | 0.87767373 |
| 90 | MP0010630_abnormal_cardiac_muscle | 0.87578820 |
| 91 | MP0002132_abnormal_respiratory_system | 0.87352648 |
| 92 | MP0005369_muscle_phenotype | 0.87104033 |
| 93 | MP0003828_pulmonary_edema | 0.85103169 |
| 94 | MP0001664_abnormal_digestion | 0.84902563 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.84812657 |
| 96 | MP0008775_abnormal_heart_ventricle | 0.84496865 |
| 97 | MP0005000_abnormal_immune_tolerance | 0.84192298 |
| 98 | MP0008469_abnormal_protein_level | 0.82979151 |
| 99 | * MP0009642_abnormal_blood_homeostasis | 0.82625875 |
| 100 | MP0000678_abnormal_parathyroid_gland | 0.82069561 |
| 101 | MP0005535_abnormal_body_temperature | 0.81719657 |
| 102 | MP0000685_abnormal_immune_system | 0.81624562 |
| 103 | MP0006138_congestive_heart_failure | 0.81307812 |
| 104 | MP0003011_delayed_dark_adaptation | 0.81093035 |
| 105 | MP0001545_abnormal_hematopoietic_system | 0.80629278 |
| 106 | MP0005397_hematopoietic_system_phenotyp | 0.80629278 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.80248697 |
| 108 | MP0000749_muscle_degeneration | 0.80020632 |
| 109 | MP0001661_extended_life_span | 0.78743722 |
| 110 | MP0005647_abnormal_sex_gland | 0.78661753 |
| 111 | MP0009115_abnormal_fat_cell | 0.77480400 |
| 112 | MP0002970_abnormal_white_adipose | 0.73647820 |
| 113 | MP0009764_decreased_sensitivity_to | 0.73439304 |
| 114 | MP0004043_abnormal_pH_regulation | 0.72394930 |
| 115 | MP0002972_abnormal_cardiac_muscle | 0.72137475 |
| 116 | MP0000750_abnormal_muscle_regeneration | 0.70962492 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.69361984 |
| 118 | MP0009697_abnormal_copulation | 0.67560517 |
| 119 | MP0000604_amyloidosis | 0.67275241 |
| 120 | MP0000747_muscle_weakness | 0.62728006 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.62057147 |
| 122 | MP0005620_abnormal_muscle_contractility | 0.61811803 |
| 123 | MP0005448_abnormal_energy_balance | 0.61774917 |
| 124 | MP0002254_reproductive_system_inflammat | 0.60749278 |
| 125 | MP0003300_gastrointestinal_ulcer | 0.56760175 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.56126075 |
| 127 | MP0002332_abnormal_exercise_endurance | 0.55268320 |
| 128 | MP0000343_altered_response_to | 0.52147898 |
| 129 | MP0003566_abnormal_cell_adhesion | 0.49173085 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.48848422 |
| 131 | MP0008438_abnormal_cutaneous_collagen | 0.48666170 |
| 132 | MP0001853_heart_inflammation | 0.48358642 |
| 133 | MP0002796_impaired_skin_barrier | 0.48105025 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.47329500 |
| 135 | MP0005220_abnormal_exocrine_pancreas | 0.47310427 |
| 136 | MP0008961_abnormal_basal_metabolism | 0.46516449 |
| 137 | MP0003137_abnormal_impulse_conducting | 0.46214593 |
| 138 | MP0009672_abnormal_birth_weight | 0.44674486 |
| 139 | MP0001765_abnormal_ion_homeostasis | 0.44396221 |
| 140 | MP0000249_abnormal_blood_vessel | 0.43625253 |
| 141 | MP0003953_abnormal_hormone_level | 0.43047131 |
| 142 | MP0002106_abnormal_muscle_physiology | 0.42538434 |
| 143 | MP0008873_increased_physiological_sensi | 0.41051060 |
| 144 | MP0005167_abnormal_blood-brain_barrier | 0.40734536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.49290683 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.42849388 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.38815689 |
| 4 | Xanthomatosis (HP:0000991) | 5.19134342 |
| 5 | Hyperglycinuria (HP:0003108) | 5.12622204 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.93784254 |
| 7 | Hyperammonemia (HP:0001987) | 4.93568490 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 4.80141581 |
| 9 | Hypoglycemic coma (HP:0001325) | 4.71718589 |
| 10 | Nemaline bodies (HP:0003798) | 4.70482986 |
| 11 | Ketosis (HP:0001946) | 4.69467947 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.66414925 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.66414925 |
| 14 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.65221072 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.55497250 |
| 16 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.54618428 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 4.36350145 |
| 18 | Hyperglycinemia (HP:0002154) | 4.32604014 |
| 19 | Prolonged partial thromboplastin time (HP:0003645) | 4.21644765 |
| 20 | Ketoacidosis (HP:0001993) | 4.01085428 |
| 21 | Complement deficiency (HP:0004431) | 3.98469936 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.95575137 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.91353392 |
| 24 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.87403744 |
| 25 | Myopathic facies (HP:0002058) | 3.84892372 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.84294577 |
| 27 | Type 1 muscle fiber predominance (HP:0003803) | 3.79846816 |
| 28 | * Dicarboxylic aciduria (HP:0003215) | 3.65996558 |
| 29 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.65996558 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.61247237 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.51697180 |
| 32 | Epidermoid cyst (HP:0200040) | 3.48451207 |
| 33 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.47909936 |
| 34 | Myoglobinuria (HP:0002913) | 3.44763594 |
| 35 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.44597959 |
| 36 | Joint hemorrhage (HP:0005261) | 3.25149360 |
| 37 | Abnormality of methionine metabolism (HP:0010901) | 3.15963584 |
| 38 | Generalized aminoaciduria (HP:0002909) | 3.14050305 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 3.10778610 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.06847812 |
| 41 | Gout (HP:0001997) | 3.04447223 |
| 42 | Rhabdomyolysis (HP:0003201) | 2.99956507 |
| 43 | Abnormality of complement system (HP:0005339) | 2.92266545 |
| 44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.91858718 |
| 45 | * Metabolic acidosis (HP:0001942) | 2.90522292 |
| 46 | Abnormality of purine metabolism (HP:0004352) | 2.88701634 |
| 47 | Fat malabsorption (HP:0002630) | 2.87593741 |
| 48 | * Lethargy (HP:0001254) | 2.87258635 |
| 49 | Cerebral edema (HP:0002181) | 2.85612875 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.84746058 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.84212936 |
| 52 | Hypercholesterolemia (HP:0003124) | 2.82387974 |
| 53 | Neck muscle weakness (HP:0000467) | 2.81501056 |
| 54 | EMG: myopathic abnormalities (HP:0003458) | 2.80233774 |
| 55 | Cerebral palsy (HP:0100021) | 2.80028414 |
| 56 | Muscle stiffness (HP:0003552) | 2.78634803 |
| 57 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.76834905 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 2.75781854 |
| 59 | Hyperbilirubinemia (HP:0002904) | 2.70255093 |
| 60 | Delayed CNS myelination (HP:0002188) | 2.69462352 |
| 61 | Proximal tubulopathy (HP:0000114) | 2.69441124 |
| 62 | Muscle fiber splitting (HP:0003555) | 2.68740668 |
| 63 | Glomerulonephritis (HP:0000099) | 2.64675333 |
| 64 | Skin nodule (HP:0200036) | 2.58287233 |
| 65 | Nausea (HP:0002018) | 2.54458455 |
| 66 | Increased variability in muscle fiber diameter (HP:0003557) | 2.53189406 |
| 67 | Myocardial infarction (HP:0001658) | 2.49617627 |
| 68 | Bulbar palsy (HP:0001283) | 2.49079448 |
| 69 | Vomiting (HP:0002013) | 2.48882682 |
| 70 | Abnormality of proline metabolism (HP:0010907) | 2.46454336 |
| 71 | Hydroxyprolinuria (HP:0003080) | 2.46454336 |
| 72 | Hyporeflexia of lower limbs (HP:0002600) | 2.45648276 |
| 73 | Hepatic necrosis (HP:0002605) | 2.45583876 |
| 74 | Abnormal cartilage morphology (HP:0002763) | 2.42914478 |
| 75 | Hepatocellular carcinoma (HP:0001402) | 2.37001085 |
| 76 | Ileus (HP:0002595) | 2.36203133 |
| 77 | Eczematoid dermatitis (HP:0000976) | 2.36105878 |
| 78 | Increased purine levels (HP:0004368) | 2.34016378 |
| 79 | Hyperuricemia (HP:0002149) | 2.34016378 |
| 80 | Late onset (HP:0003584) | 2.33139980 |
| 81 | Cholelithiasis (HP:0001081) | 2.29148765 |
| 82 | Increased muscle lipid content (HP:0009058) | 2.28120798 |
| 83 | Distal arthrogryposis (HP:0005684) | 2.26220727 |
| 84 | Distal lower limb amyotrophy (HP:0008944) | 2.25424659 |
| 85 | Spastic diplegia (HP:0001264) | 2.24601264 |
| 86 | Right ventricular cardiomyopathy (HP:0011663) | 2.24567868 |
| 87 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.24471676 |
| 88 | Difficulty running (HP:0009046) | 2.22777463 |
| 89 | Hypoglycemic seizures (HP:0002173) | 2.22685157 |
| 90 | Abnormal gallbladder morphology (HP:0012437) | 2.19316423 |
| 91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.17555500 |
| 92 | Ventricular tachycardia (HP:0004756) | 2.15310172 |
| 93 | Pancreatitis (HP:0001733) | 2.13961287 |
| 94 | Conjugated hyperbilirubinemia (HP:0002908) | 2.13678185 |
| 95 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.12852441 |
| 96 | Vascular calcification (HP:0004934) | 2.10715616 |
| 97 | Exercise-induced myalgia (HP:0003738) | 2.10713561 |
| 98 | Palpitations (HP:0001962) | 2.09963281 |
| 99 | Rimmed vacuoles (HP:0003805) | 2.09845831 |
| 100 | Ragged-red muscle fibers (HP:0003200) | 2.09303858 |
| 101 | Sudden death (HP:0001699) | 2.08503834 |
| 102 | Malnutrition (HP:0004395) | 2.07564291 |
| 103 | Hypertriglyceridemia (HP:0002155) | 2.07317621 |
| 104 | Steatorrhea (HP:0002570) | 2.06567985 |
| 105 | Renal cortical cysts (HP:0000803) | 2.05439434 |
| 106 | Systemic lupus erythematosus (HP:0002725) | 2.05384385 |
| 107 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.05032983 |
| 108 | Esophageal varix (HP:0002040) | 2.03895618 |
| 109 | Round ear (HP:0100830) | 2.03430532 |
| 110 | Colitis (HP:0002583) | 2.01382023 |
| 111 | Glycosuria (HP:0003076) | 2.01273333 |
| 112 | Abnormality of urine glucose concentration (HP:0011016) | 2.01273333 |
| 113 | Increased intramyocellular lipid droplets (HP:0012240) | 2.00642102 |
| 114 | Sensorimotor neuropathy (HP:0007141) | 1.99650980 |
| 115 | Irritability (HP:0000737) | 1.99324267 |
| 116 | Dilated cardiomyopathy (HP:0001644) | 1.99310910 |
| 117 | Exercise-induced muscle cramps (HP:0003710) | 1.97785160 |
| 118 | Ulnar deviation of the wrist (HP:0003049) | 1.97449123 |
| 119 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96703154 |
| 120 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96703154 |
| 121 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96703154 |
| 122 | Multiple enchondromatosis (HP:0005701) | 1.92675279 |
| 123 | Nephritis (HP:0000123) | 1.92399359 |
| 124 | Cardiovascular calcification (HP:0011915) | 1.91946212 |
| 125 | Growth hormone excess (HP:0000845) | 1.90317810 |
| 126 | Hyperglycemia (HP:0003074) | 1.88503393 |
| 127 | Calf muscle hypertrophy (HP:0008981) | 1.88155195 |
| 128 | Bundle branch block (HP:0011710) | 1.86470415 |
| 129 | Atrioventricular block (HP:0001678) | 1.85732406 |
| 130 | Abnormal gallbladder physiology (HP:0012438) | 1.84104092 |
| 131 | Cholecystitis (HP:0001082) | 1.84104092 |
| 132 | Asymmetric septal hypertrophy (HP:0001670) | 1.83479715 |
| 133 | Axonal loss (HP:0003447) | 1.83443714 |
| 134 | Spontaneous abortion (HP:0005268) | 1.82892729 |
| 135 | Brushfield spots (HP:0001088) | 1.82493106 |
| 136 | Methylmalonic aciduria (HP:0012120) | 1.82355269 |
| 137 | Abnormality of the calf musculature (HP:0001430) | 1.80863363 |
| 138 | Polycythemia (HP:0001901) | 1.80542335 |
| 139 | Hemorrhage of the eye (HP:0011885) | 1.80381037 |
| 140 | Increased connective tissue (HP:0009025) | 1.79455988 |
| 141 | Vertebral compression fractures (HP:0002953) | 1.78268583 |
| 142 | Purpura (HP:0000979) | 1.78104753 |
| 143 | Alkalosis (HP:0001948) | 1.77960260 |
| 144 | Amyloidosis (HP:0011034) | 1.77301065 |
| 145 | Chronic diarrhea (HP:0002028) | 1.74456456 |
| 146 | Increased serum ferritin (HP:0003281) | 1.73703535 |
| 147 | Dysostosis multiplex (HP:0000943) | 1.72688462 |
| 148 | Lipoatrophy (HP:0100578) | 1.70187055 |
| 149 | Generalized muscle weakness (HP:0003324) | 1.69532812 |
| 150 | Progressive muscle weakness (HP:0003323) | 1.68183849 |
| 151 | Abnormal pupillary function (HP:0007686) | 1.67473753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.53907924 |
| 2 | TRIB3 | 4.23192448 |
| 3 | PKN2 | 3.87765743 |
| 4 | ERN1 | 3.45931107 |
| 5 | SIK1 | 3.13657403 |
| 6 | FGFR4 | 2.80597648 |
| 7 | TTN | 2.63302193 |
| 8 | PDK4 | 2.57442533 |
| 9 | PDK3 | 2.57442533 |
| 10 | TESK2 | 2.27820718 |
| 11 | FLT3 | 2.26090840 |
| 12 | PRPF4B | 2.08622147 |
| 13 | TESK1 | 1.96576910 |
| 14 | NEK1 | 1.78443628 |
| 15 | MST1R | 1.71584250 |
| 16 | MAP2K3 | 1.56583912 |
| 17 | LMTK2 | 1.52424499 |
| 18 | ACVR1B | 1.52308204 |
| 19 | PDK2 | 1.49013349 |
| 20 | MAP3K10 | 1.43374756 |
| 21 | MAP3K7 | 1.42705000 |
| 22 | MAPK11 | 1.41578349 |
| 23 | INSRR | 1.40733914 |
| 24 | MYLK | 1.40727432 |
| 25 | PTK6 | 1.38721273 |
| 26 | STK38L | 1.35208550 |
| 27 | CAMK1D | 1.34867526 |
| 28 | PIM2 | 1.33634421 |
| 29 | TIE1 | 1.32721656 |
| 30 | PINK1 | 1.31089060 |
| 31 | MAP3K1 | 1.29874117 |
| 32 | KDR | 1.28716219 |
| 33 | ARAF | 1.26058382 |
| 34 | PIK3CA | 1.24389310 |
| 35 | TAOK2 | 1.23637807 |
| 36 | OBSCN | 1.19120067 |
| 37 | PRKAA2 | 1.19003341 |
| 38 | TYK2 | 1.18087792 |
| 39 | SMG1 | 1.16489395 |
| 40 | TGFBR2 | 1.14629561 |
| 41 | RIPK1 | 1.13447563 |
| 42 | SCYL2 | 1.11018994 |
| 43 | NEK9 | 1.08167514 |
| 44 | RIPK4 | 1.02834352 |
| 45 | MAP3K3 | 0.98216153 |
| 46 | PHKG1 | 0.96168871 |
| 47 | PHKG2 | 0.96168871 |
| 48 | ERBB4 | 0.95327015 |
| 49 | EEF2K | 0.94984622 |
| 50 | TBK1 | 0.93838307 |
| 51 | PIK3CG | 0.93396425 |
| 52 | LATS1 | 0.90885715 |
| 53 | MAP3K11 | 0.88795765 |
| 54 | IKBKE | 0.88757883 |
| 55 | PRKAA1 | 0.86041664 |
| 56 | MAP3K13 | 0.85366888 |
| 57 | GRK6 | 0.85200977 |
| 58 | TAOK3 | 0.82961397 |
| 59 | MAPKAPK3 | 0.81664145 |
| 60 | PDGFRA | 0.81626618 |
| 61 | LRRK2 | 0.80989070 |
| 62 | CDC42BPA | 0.80607888 |
| 63 | CDK4 | 0.79990384 |
| 64 | EPHB1 | 0.79919159 |
| 65 | TAOK1 | 0.78284746 |
| 66 | JAK2 | 0.78233167 |
| 67 | ABL2 | 0.78193555 |
| 68 | WNK4 | 0.77169664 |
| 69 | MAP3K14 | 0.76727595 |
| 70 | BLK | 0.75858397 |
| 71 | KSR2 | 0.75845224 |
| 72 | JAK3 | 0.75175659 |
| 73 | ICK | 0.74885648 |
| 74 | DDR2 | 0.74548244 |
| 75 | MATK | 0.74068168 |
| 76 | MAPK12 | 0.71778099 |
| 77 | MAP2K4 | 0.68547036 |
| 78 | NME2 | 0.68386371 |
| 79 | TXK | 0.68025921 |
| 80 | PDPK1 | 0.67871682 |
| 81 | CDK6 | 0.67115666 |
| 82 | MAP2K2 | 0.66300742 |
| 83 | MUSK | 0.66133310 |
| 84 | MET | 0.65332852 |
| 85 | MTOR | 0.65263404 |
| 86 | DMPK | 0.65101330 |
| 87 | SYK | 0.62601617 |
| 88 | TNK2 | 0.61615686 |
| 89 | IRAK4 | 0.61059844 |
| 90 | EPHA3 | 0.60771954 |
| 91 | MAP4K1 | 0.59789627 |
| 92 | JAK1 | 0.59088510 |
| 93 | FES | 0.58251052 |
| 94 | MAPK7 | 0.58119842 |
| 95 | MAPK4 | 0.56449891 |
| 96 | RPS6KC1 | 0.56172538 |
| 97 | RPS6KL1 | 0.56172538 |
| 98 | PRKACG | 0.56004904 |
| 99 | CAMK2G | 0.55891965 |
| 100 | ILK | 0.54247649 |
| 101 | CSF1R | 0.52983393 |
| 102 | PDK1 | 0.52426976 |
| 103 | MAP3K6 | 0.51841807 |
| 104 | PRKD1 | 0.51208801 |
| 105 | MAP2K1 | 0.50904885 |
| 106 | CSK | 0.50785907 |
| 107 | DYRK1B | 0.50674607 |
| 108 | MAP3K5 | 0.49007347 |
| 109 | BTK | 0.46001709 |
| 110 | GSK3A | 0.45897295 |
| 111 | CAMK1G | 0.45762654 |
| 112 | MAP2K6 | 0.45426547 |
| 113 | IKBKB | 0.44785452 |
| 114 | LIMK1 | 0.44335686 |
| 115 | RPS6KA6 | 0.42237268 |
| 116 | STK4 | 0.41825028 |
| 117 | PAK4 | 0.41761536 |
| 118 | RPS6KA2 | 0.40071822 |
| 119 | AKT2 | 0.39052037 |
| 120 | TGFBR1 | 0.38169453 |
| 121 | DAPK3 | 0.36855126 |
| 122 | EPHA2 | 0.36487394 |
| 123 | MAP3K8 | 0.35580078 |
| 124 | STK10 | 0.35220892 |
| 125 | IRAK3 | 0.35139125 |
| 126 | ZAP70 | 0.34053919 |
| 127 | PTK2 | 0.33964416 |
| 128 | PRKG2 | 0.33902633 |
| 129 | FGFR3 | 0.32944581 |
| 130 | PAK3 | 0.32601142 |
| 131 | ERBB2 | 0.30417175 |
| 132 | EPHB2 | 0.30317478 |
| 133 | FRK | 0.30104403 |
| 134 | RPS6KB2 | 0.29443229 |
| 135 | FGFR2 | 0.28206375 |
| 136 | CAMK4 | 0.28022841 |
| 137 | KIT | 0.27538299 |
| 138 | BMX | 0.26191365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.52246542 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26392679 |
| 3 | * Fatty acid degradation_Homo sapiens_hsa00071 | 3.11664657 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.99437133 |
| 5 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.98277834 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93824407 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.93598587 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.82881765 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.81014008 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.61829929 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59180074 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.45742862 |
| 13 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 2.32232787 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.31488629 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.23702957 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.21390664 |
| 17 | * Butanoate metabolism_Homo sapiens_hsa00650 | 2.16258560 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08603143 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.07744028 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.99429444 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.97543740 |
| 22 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.89533359 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84675931 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72126255 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.63805438 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60923253 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.52830943 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.49568151 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49071995 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.48860229 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48409321 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.48309719 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.46975135 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.43837340 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42724627 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41288533 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39502123 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36683360 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36278572 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36216080 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28241981 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.26861863 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26068267 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.25645678 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25106649 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23066061 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22966490 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 1.15586110 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12368658 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08177765 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04497309 |
| 52 | Mineral absorption_Homo sapiens_hsa04978 | 1.03162560 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 1.02921123 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01677301 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95049300 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.95005985 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90541468 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88853404 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.87704045 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85349879 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.84205176 |
| 62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.82415146 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80112369 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76356638 |
| 65 | Allograft rejection_Homo sapiens_hsa05330 | 0.74654406 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72562111 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72555369 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70003235 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66361604 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62868028 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61517076 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.60872130 |
| 73 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58202987 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57787930 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57103212 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55794252 |
| 77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.55479210 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54628444 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52573474 |
| 80 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.51887551 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.51025591 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47333169 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46139161 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44008841 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42317663 |
| 86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.37517890 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.37130317 |
| 88 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.36846101 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.36067147 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34643468 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29021929 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22476233 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.21004268 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.20397150 |
| 95 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.19433997 |
| 96 | Parkinsons disease_Homo sapiens_hsa05012 | 0.19335392 |
| 97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.18758840 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17984888 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17634121 |
| 100 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.16069948 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11797700 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.11535373 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10515716 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.09672157 |
| 105 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.06375990 |
| 106 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1838779 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | -0.1708842 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | -0.1529378 |
| 109 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1435197 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1317418 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1267576 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | -0.1092008 |
| 113 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0899007 |
| 114 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0726977 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0685413 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0675193 |
| 117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0521050 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0479588 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0218170 |
| 120 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0024969 |

